Dianomi Therapeutics Overview
- Founded
- 2017
- Status
- Private
- Employees
- 8
- Latest Deal Type
- Series A
- (In Progress)
- Investors
- 1
Dianomi Therapeutics General Information
Description
Owner and operator of a biopharmaceutical company focused on developing treatments for inflammatory diseases, initially targeting osteoarthritis (OA). The company's mineral coated microparticle (MCM) technology has the ability to provide sustained release delivery of active biologics, an issue many traditional drug delivery systems struggle with, providing patients with improved, sustained-release delivery of active biologics.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 504 South Rosa Road
- Suite 200
- Madison, WI 53719
- United States
+1 (303) 000-0000
Dianomi Therapeutics Timeline
Dianomi Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series A) | 09-Feb-2021 | 00.00 | 0000 | In Progress | Pre-Clinical Trials | |
| 3. Angel (individual) | 00000 | 00.00 | Completed | Pre-Clinical Trials | ||
| 2. Corporate | 04-Feb-2019 | $3M | $3.19M | Completed | Pre-Clinical Trials | |
| 1. Angel (individual) | 25-Jan-2019 | $185K | $185K | Completed | Pre-Clinical Trials |
Dianomi Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Owner and operator of a biopharmaceutical company focused on developing treatments for inflammatory diseases, initially
Drug Discovery
Madison, WI
8
As of 2021
00.00
000
0000-00-00
00000000000
00.00
000000 0
ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore e
0000000000000
Cambridge, MA
000
As of 0000
00000
000000 - 000
00000
00000000
e velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident,
0000 000000000
Utrecht, Netherlands
00
As of 0000
00.00
00.00
0000-00-00
000000&0
00.00
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialDianomi Therapeutics Competitors (30)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Jounce Therapeutics | Corporation | Cambridge, MA | 000 | 00000 | 000000 - 000 | 00000 |
| 000000000 00000000 | Formerly VC-backed | Utrecht, Netherlands | 00 | 00.00 | 000000&0 | 00.00 |
| 0000000 0000000000 | Formerly Angel backed | New York, NY | 00 | 000.00 | 000000000 | 000.00 |
| 00000000 | Venture Capital-Backed | San Carlos, CA | 00 | 00000 | 00000000000 | 00000 |
| 000000000 | Formerly VC-backed | Gaithersburg, MD | 00 | 00000 | 00000000 | 00000 |
Dianomi Therapeutics Executive Team (6)
Dianomi Therapeutics Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Barry Kurokawa | Dianomi Therapeutics | Co-Founder, Chief Executive Officer & Chairman | 000 0000 |
| Martin Ostrowski JD | Dianomi Therapeutics | Co-Founder, Chief Operating Officer, President & Board Member | 000 0000 |
Dianomi Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialDianomi Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Ligand Pharmaceuticals | Corporation | Minority | 000 0000 | 000000 0 |